tiprankstipranks
Trending News
More News >
Medicamen Biotech Limited (IN:MEDICAMEQ)
:MEDICAMEQ
India Market
Advertisement

Medicamen Biotech Limited (MEDICAMEQ) Price & Analysis

Compare
0 Followers

MEDICAMEQ Stock Chart & Stats


MEDICAMEQ FAQ

What was Medicamen Biotech Limited’s price range in the past 12 months?
Medicamen Biotech Limited lowest stock price was ₹362.95 and its highest was ₹630.00 in the past 12 months.
    What is Medicamen Biotech Limited’s market cap?
    Medicamen Biotech Limited’s market cap is ₹5.13B.
      When is Medicamen Biotech Limited’s upcoming earnings report date?
      Medicamen Biotech Limited’s upcoming earnings report date is Aug 07, 2025 which is 2 days ago.
        How were Medicamen Biotech Limited’s earnings last quarter?
        Medicamen Biotech Limited released its earnings results on May 30, 2025. The company reported ₹1.47 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.47.
          Is Medicamen Biotech Limited overvalued?
          According to Wall Street analysts Medicamen Biotech Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Medicamen Biotech Limited pay dividends?
            Medicamen Biotech Limited pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.27%. See more information on Medicamen Biotech Limited dividends here
              What is Medicamen Biotech Limited’s EPS estimate?
              Medicamen Biotech Limited’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Medicamen Biotech Limited have?
              Medicamen Biotech Limited has 13,562,815 shares outstanding.
                What happened to Medicamen Biotech Limited’s price movement after its last earnings report?
                Medicamen Biotech Limited reported an EPS of ₹1.47 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.189%.
                  Which hedge fund is a major shareholder of Medicamen Biotech Limited?
                  Currently, no hedge funds are holding shares in IN:MEDICAMEQ

                  Company Description

                  Medicamen Biotech Limited

                  Medicamen Biotech Limited manufactures and sells pharmaceutical formulations in India. The company offers its products in various forms, including tablets, capsules, liquid and dry syrups, and ointments. It also provides oral rehydration solution, mouth wash, and dental care products. The company was incorporated in 1993 and is based in New Delhi, India.

                  Medicamen Biotech Limited (MEDICAMEQ) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Ind-Swift Laboratories Ltd.
                  Nectar Lifesciences Ltd.
                  Sakar Healthcare Ltd
                  Venus Remedies Limited
                  Zim Laboratories Ltd.
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis